Advertisement

International Journal of Clinical Pharmacy

, Volume 36, Issue 5, pp 1069–1076 | Cite as

Development of consensus guidance to facilitate service redesign around pharmacist prescribing in UK hospital practice

  • Antonella Tonna
  • Dorothy McCaig
  • Lesley Diack
  • Bernice West
  • Derek Stewart
Research Article

Abstract

Background The last decade has seen a drive towards non-medical prescribing in the United Kingdom (UK). However, there is a dearth of any published literature on applying the principles of service redesign to support pharmacist prescribing in any sphere of practice. Objective To develop consensus guidance to facilitate service redesign around pharmacist prescribing. Setting UK hospital practice. Methods The Delphi technique was used to measure consensus of a panel of expert opinion holders in Scotland. Individuals with key strategic and operational roles in implementing initiatives of pharmacy practice and medicines management were recruited as experts. An electronic questionnaire consisting of 30 statements related to pharmacist prescribing service redesign was developed. These were presented as five-point Likert scales with illustrative quotes. Main outcome measures Consensus, defined as 70 % of panel members agreeing (ranked strongly agree/agree) with each statement. Results Responses were obtained from 35/40 (87.5 %) experts in round one and 29 (72.5 %) in round two. Consensus in round one was achieved for 27/30 of statements relating to aspects of generic ‘service development’ (e.g. succession planning, multidisciplinary working, quality evaluation, practice development and outcome measures) and ‘pharmacist prescribing role development’ (e.g. education and future orientation of service). Issues of disagreement were around targeting of pharmacist prescribing to clinical specialities and financial remuneration for prescribing in the hospital setting. Conclusion Consensus guidance has been developed to facilitate service redesign around hospital pharmacist prescribing.

Keywords

Consensus guidance Pharmacist prescribing Secondary care Service redesign United Kingdom 

Notes

Acknowledgments

The authors would like to acknowledge the participation of all external opinion holders.

Funding

The research was funded by Robert Gordon University.

Conflicts of interest

There are no conflicts of interest to declare.

References

  1. 1.
    Stewart D, MacLure K, George J. Educating non-medical prescribers. Brit J Clin Pharm. 2013;74(4):662–7.CrossRefGoogle Scholar
  2. 2.
    Latter S, Blenkinsopp A, Smith A, Chapman S, Tinelli M, Gerard K, Little P, Celino N, Granby T, Nicholls P, Dorer G. Evaluation of nurse and pharmacist independent prescribing. London: Department of Health; 2010.Google Scholar
  3. 3.
    Department of Health (2014) Non-medical prescribing programme. http://www.dhsspsni.gov.uk/non-medical-prescribing. Accessed Jul 2014.
  4. 4.
    Tonna AP, Stewart D, West B, McCaig D. Pharmacist prescribing in the UK—a literature review of current research and practice. J Clin Pharm Ther. 2007;32:545–56.PubMedCrossRefGoogle Scholar
  5. 5.
    Cooper RJ, Anderson C, Avery T, Bissell P, Guillaume L, Hutchinson A, James V, Lymn J, McIntosh A, Murphy E. Nurse and pharmacist supplementary prescribing in the UK—a thematic review of the literature. Health Policy. 2008;85:277–92.PubMedCrossRefGoogle Scholar
  6. 6.
    General Pharmaceutical Council (2014) Indicative curriculum for the education and training of pharmacist independent prescribers, London. http://www.pharmacyregulation.org/sites/default/files/Pharmacist%20Independent%20Prescribing%20-%20Learning%20Outcomes%20and%20Indicative%20Content.pdf. Accessed Jul 2014.
  7. 7.
    George J, McCaig D, Bond C, Cunningham S, Diack L, Watson A, Stewart D. Supplementary prescribing: early experiences of pharmacists in Great Britain. Ann Pharmacother. 2006;40:843–1850.Google Scholar
  8. 8.
    Smalley L. Patients’ experiences of pharmacist-led supplementary prescribing in primary care. Pharm J. 2006;276:567–9.Google Scholar
  9. 9.
    Hobson RJ, Sewell GJ. Supplementary prescribing by pharmacists in England. Am J Health Syst Pharm. 2006;63(3):244–53.PubMedCrossRefGoogle Scholar
  10. 10.
    George J, McCaig D, Bond C, Cunningham S, Diack L, Stewart D. Benefits and challenges of prescribing training and implementation: perceptions and early experiences of RPSGB prescribers. Int J Pharm Pract. 2007;15:23–30.CrossRefGoogle Scholar
  11. 11.
    George J, Bond C, McCaig D, Cleland J, Cunningham S, Diack L, Stewart D. Experiential learning as part of pharmacist supplementary prescribing training: feedback from trainees and their mentors. Ann Pharmacother. 2007;41:1031–8.PubMedCrossRefGoogle Scholar
  12. 12.
    Cooper R, Lymn J, Anderson C, Avery A, Bissel P, Guillaume L, Hutchinson A, Murphy E, Ratcliffe J, Ward P. Learning to prescribe–pharmacists’ experiences of supplementary prescribing training in England. BMC Med Ed. 2008;8:57.CrossRefGoogle Scholar
  13. 13.
    Stewart DC, George J, Bond CM, Cunningham ITS, Diack LH, McCaig DJ. Exploring patients’ perspectives of pharmacist supplementary prescribing in Scotland. Pharm World Sci. 2008;30:892–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Stewart DC, George J, Bond CM, Diack LH, McCaig DJ, Cunningham ITS. Views of pharmacist prescribers, doctors and patients on pharmacist prescribing implementation. Int J Pharm Pract. 2009;17:89–94.PubMedCrossRefGoogle Scholar
  15. 15.
    Hobson RJ, Scott J, Sutton J. Pharmacists and nurses as independent prescribers: exploring the patient’s perspective. Fam Pract. 2010;27(1):110–20.PubMedCrossRefGoogle Scholar
  16. 16.
    Ross S, Bond C, Rothnie H, Thomas S, MacLeod MJ. What is the scale of prescribing errors committed by junior doctors? A systematic review. Brit J Clin Pharm. 2009;67(6):629–40.PubMedCrossRefPubMedCentralGoogle Scholar
  17. 17.
    NHS Institute for Innovation and Improvement (2014) Quality and service improvement tools. http://www.institute.nhs.uk/quality_and_service_improvement_tools/quality_and_service_improvement_tools/role_redesign.html. Accessed Jul 2014.
  18. 18.
    Campbell SM, Cantrill JA. Consensus methods in prescribing research. J Clin Pharm Ther. 2001;26:5–14.PubMedCrossRefGoogle Scholar
  19. 19.
    James DH, Hatten S, Roberts D, John DN. Identifying criteria for assessing the quality of medicines use review referral documentation by community pharmacists. Int J Pharm Pract. 2008;16:365–74.CrossRefGoogle Scholar
  20. 20.
    Franklin BD, O’Grady K. Dispensing errors in community pharmacy: frequency, clinical significance and potential impact of authentication at the point of dispensing. Int J Pharm Pract. 2007;15:273–81.CrossRefGoogle Scholar
  21. 21.
    Pfleger DE, McHattie LW, Diack HL, McCaig DJ, Stewart DC. Developing consensus around the pharmaceutical public health competencies for community pharmacists in Scotland. Pharm World Sci. 2008;30:111–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Power A, McKellar S, Hudson S. A consensus model for delivery of structured pharmaceutical care for the patient with type 2 diabetes mellitus by Scottish community pharmacists. Int J Pharm Pract. 2007;15:283–90.CrossRefGoogle Scholar
  23. 23.
    McDermott JH, Caiola SM, Kuhn KF, Stritter FT, Beza J. A Delphi survey to identify the components of a community pharmacy clerkship. Am J Pharm Ed. 1995;59:334–41.Google Scholar
  24. 24.
    Meadows AB, Maine LL, Keyes EK, Pearson K, Finstuen K. Pharmacy executive leadership issues and associated skills, knowledge, and abilities. J Am Pharm Ass. 2005;45:55–62.CrossRefGoogle Scholar
  25. 25.
    Meadows AB, Finstuen K, Hudak RP. Pharmacy executives: leadership issues and associated skills, knowledge and abilities in the US Department of Defense. J Am Pharm Ass. 2003;43:412–8.CrossRefGoogle Scholar
  26. 26.
    Chan A, Tan S, Wong CM, Yap KY, Ko Y. Clinically significant drug–drug interactions between oral anticancer agents and nonanticancer agents: a Delphi survey of oncology pharmacists. Clin Ther. 2009;31:2379–8627.PubMedCrossRefGoogle Scholar
  27. 27.
    Jones J, Hunter D. Consensus methods for medical and health services research. Brit Med J. 1995;311:376–80.PubMedCrossRefPubMedCentralGoogle Scholar
  28. 28.
    Tonna AP, Stewart DC, West B, McCaig DJ. Exploring pharmacists’ perceptions of the feasibility and value of pharmacist prescribing of antimicrobials in secondary care in Scotland. Int J Pharm Pract. 2010;18:312–9.PubMedCrossRefGoogle Scholar
  29. 29.
    Crisp J, Pelletier D, Duffield C, Adams A, Nagy S. The Delphi Method? Nurs Res. 1997;46:116–8.PubMedCrossRefGoogle Scholar
  30. 30.
    Von Der Gracht HA. Consensus measurement in Delphi studies: review and implications for future quality assurance. Technol Forecast Soc Change. 2012;79:1525–36.CrossRefGoogle Scholar
  31. 31.
    NHS Health Development Agency. Clarifying health impact assessment, integrated impact assessment and health needs assessment. London: Health Development Agency; 2003. ISBN 1-84279-242-3.Google Scholar
  32. 32.
    Tolson D, West B. An exploration of role development in nursing and midwifery. Edinburgh: NHS Health Scotland; 2002.Google Scholar

Copyright information

© Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie 2014

Authors and Affiliations

  • Antonella Tonna
    • 1
  • Dorothy McCaig
    • 1
  • Lesley Diack
    • 1
  • Bernice West
    • 2
  • Derek Stewart
    • 1
  1. 1.School of Pharmacy and Life SciencesRobert Gordon UniversityAberdeenUK
  2. 2.School of Nursing and MidwiferyRobert Gordon UniversityAberdeenUK

Personalised recommendations